Four weeks later, the size and weight of the tumour in the CAV-1 knockdown group was considerably decreased compared with that in the control U87 group, the size and weight of the tumour in the CAV-1 over-expression group was considerably increased compared with that in the control U251 group (Fig. 6A–D). The gene discussed is CAV1; the disease is neoplasm.